The Freeze Drying Facility, also known as the Lyophilization Unit, is an essential support division involved in the dehydration and stabilization of vaccines, bacterial cultures, and biological reagents. By removing moisture under low temperature and vacuum conditions, the facility ensures that biological materials remain stable and effective over extended periods.
The process enhances the shelf-life, transportability, and usability of products under a wide range of environmental conditions.
The facility is equipped with advanced lyophilization and environmental monitoring systems, including:
The Freeze Drying Facility collaborates closely with production and R&D divisions to optimize lyophilization protocols for new vaccine candidates and diagnostic reagents. Continuous research is focused on improving process efficiency, product recovery, and long-term stability of sensitive biological materials.
All operations are conducted in accordance with Good Manufacturing Practices (GMP) and GLP standards. Regular equipment calibration, environmental monitoring, and documentation ensure full compliance with institutional and regulatory quality requirements.
The Freeze Drying Facility is committed to maintaining the integrity and potency of biological products through scientific precision and advanced technology — supporting the institute’s mission to deliver high-quality and stable biologicals to the field.